ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $4,000 | -20.0% | 11,048 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | 0.0% | 11,048 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | -54.5% | 11,048 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $11,000 | -66.7% | 11,048 | -58.5% | 0.00% | -50.0% |
| Q1 2016 | $33,000 | -28.3% | 26,648 | -16.3% | 0.00% | 0.0% |
| Q4 2015 | $46,000 | – | 31,848 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 17,200 | $9,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 18,332 | $9,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 949,438 | $475,000 | 0.00% |
| Virtu KCG Holdings LLC | 58,727 | $29,000 | 0.00% |
| Renaissance Technologies | 1,034,500 | $517,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 46,100 | $23,000 | 0.00% |
| DEUTSCHE BANK AG\ | 5 | $0 | 0.00% |
| CITIGROUP INC | 10,376 | $5,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 17,280 | $9,000 | 0.00% |
| MORGAN STANLEY | 8,500 | $4,000 | 0.00% |